The board of directors of medical technology company CONMED Corporation (NASDAQ:CNMD) authorised a quarterly dividend of USD0.20 per share of the company's stock, it declared on Friday.
Shareholders of record as of 13 September 2019 will receive the cash dividend on 7 October 2019.
CONMED provides surgical devices and equipment for minimally invasive procedures.
According to CONMED, its products are used by surgeons and physicians in orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project